| Therapeutic class | TdP risk a | QT prolonging drugs (ATC Code) | n (%) b |
|---|
| Antidepressants (n = 13) | Known (n = 4) | Escitalopram (N06AB10) | 4 (17.4) |
| Possible (2) | Clomipramine (N06AA04) | 1 (4.3) |
| Venlafaxine (N06AX16) | 1 (4.3) |
| Conditional (7) | Sertraline (N06AB06) | 3 (13) |
| Fluoxetine (N06CA03) | 2 (8.7) |
| Fluvoxamine (N06AB08) | 1 (4.3) |
| Paroxetine (N06AB05) | 1 (4.3) |
| Antipsychotics (5) | Known (2) | Haloperidol (N05AD01) | 1 (4.3) |
| Levosulpiride (N05AL07) | 1 (4.3) |
| Possible (2) | Risperidone (N05AX08) | 1 (4.3) |
| Aripiprazole (N05AX12) | 1 (4.3) |
| Conditional (1) | Olanzapine (N05AH03) | 1 (4.3) |
| Proton pump inhibitors (2) | Conditional (2) | Esomeprazole (A02BC05) | 2 (8.7) |
| Diuretics (2) | Conditional (2) | Hydrochlorothiazide (C03AA03) | 1 (4.3) |
| Furosemide (C03CA01) | 1 (4.3) |
| Antinausea (1) | Known (1) | Domperidone (A03FA03) | 1 (0.9) |
- a TdP risk was based on CredibleMeds® database; b Percentage calculated in total of 23 patients
